Figure 12 | Scientific Reports

Figure 12

From: Multiple omics integrative analysis identifies GARS1 as a novel prognostic and immunological biomarker: from pan-cancer to bladder cancer

Figure 12

DNA methylation levels of GARS in BLCA. (a) Promoter methylation level of GARS in normal tissues and primary tumor tissues by the UALCAN database. (b) Promoter methylation level of GARS in BLCA tissues of various tumor stages. (c) Promoter methylation level of GARS in BLCA tissues by historical subtypes. (d) The heatmap of DNA methylation at CpG sites in the GARS gene by the MethSurv database.

Back to article page